Literature DB >> 6977481

Tumour cell-antibody interactions. II. In vitro studies.

G Froese, I Berczi, L G Israels.   

Abstract

The interaction of L5178Y thymic lymphoma cells syngeneic to DBA/2 mice and of normal thymocytes with goat IgG antibodies was studied in vitro. Viable tumour and normal cells exerted a rapid, continuous and temperature-dependent destruction of antibody activity. Fractionation studies of culture supernatants from antibody-coated cells revealed that a significant portion of the antibody was completely degraded to amino acids. Tumour cells digested antibody more effectively than did normal lymphocytes. This observed degradation of antibody was most extensive at 37 degrees, significantly less at room temperature (23 degrees) and not detectable at 0 degrees. Undegraded antibody released from antibody-coated cells had also lost its antibody activity to a considerable extent. This was due to the formation of soluble antigen-antibody complexes, which was observed even at 0 degrees. Cells fixed with 10% formalin bound maximum amounts of antibody were incapable of digesting antibody even at 37 degrees and did not release immune complexes. These findings are of relevance to cancer immunodiagnosis and immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977481      PMCID: PMC1555266     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Shedding of anti-IgM from antibody-coated human lymphoma lines: differences between Epstein-Barr virus-negative lines and their virus-converted sublines.

Authors:  E Yefenof; L Lundin; G Klein
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

2.  Antibody-induced redistribution of normal and tumor associated surface antigens.

Authors:  E Yefenof; G Klein
Journal:  Exp Cell Res       Date:  1974-10       Impact factor: 3.905

3.  Tumor cell mediated degradation in vitro of antitumor antibodies.

Authors:  Y Keisari; I P Witz
Journal:  Haematol Blood Transfus       Date:  1979

4.  Surface immunoglobulins of rat immunocytes: quantitation and fate of cell-bound peroxidase-labeled antibody and Fab fragment.

Authors:  J C Antoine; S Avrameas
Journal:  Eur J Immunol       Date:  1974-07       Impact factor: 5.532

5.  Antibody-induced redistribution of CEA on the cell surface: utilization in separation of CEA and isoantigen A.

Authors:  K L Rosenthal; J L Palmer; J A Harris; W E Rawls; W A Tompkins
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

6.  Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro.

Authors:  J Ritz; J M Pesando; J Notis-McConarty; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

7.  Interaction of isoantibody and cytotoxic lymphocytes with allogeneic tumor cells.

Authors:  R B Faanes; Y S Choi
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

8.  Immunofluorescent studies on the occurrence of cathepsin B1 at tumor cell surfaces.

Authors:  B Sylvén; O Snellman; P Sträuli
Journal:  Virchows Arch B Cell Pathol       Date:  1974

9.  Antibody-induced modulation and shedding of mammary tumor virus antigens on the surfaces of GR ascites leukemia cells as compared with normal antigens.

Authors:  J Calafat; J Hilgers; W J Van Bitterswijk; M Verbeet; P C Hageman
Journal:  J Natl Cancer Inst       Date:  1976-05       Impact factor: 13.506

10.  Serine enzymes released by cultured neoplastic cells.

Authors:  K Danø; E Reich
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Immunoglobulins as targeting agents for liposome encapsulated drugs.

Authors:  P A Toonen; D J Crommelin
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

2.  Use of monoclonal antibodies and liposomes to improve drug delivery. Present status and future implications.

Authors:  G Gregoriadis
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

3.  Tumour cell-antibody interactions. I. In vivo experiments.

Authors:  G Froese; I Berczi; L G Israels
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.